<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109132">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01731964</url>
  </required_header>
  <id_info>
    <org_study_id>WA-NG-001 ASSAF HAROFEH</org_study_id>
    <nct_id>NCT01731964</nct_id>
  </id_info>
  <brief_title>Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration</brief_title>
  <official_title>Pilot Study of WA-NG Telescope Prosthesis in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VisionCare Ophthalmic Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VisionCare Ophthalmic Technologies, Inc.</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to evaluate the safety of the Model WA-NG telescope prosthesis in
      patients with bilateral moderate to profound central vision impairment due to end-stage
      age-related macular degeneration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be screened for eligibility and informed consent will be obtained from those
      who meet screening criteria and are interested in participating in the study. Eligible
      patients will be examined preoperatively to obtain a medical history and to establish a
      baseline for ocular condition. Baseline measurements will include successful use of an
      external telescope.

      Postoperatively, patients will undergo ophthalmic evaluation at regular intervals as
      specified in this protocol and will be required to return for 6 to 10 additional visits for
      vision training with a low vision specialist.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Positional stability assessed by slit lamp examination and anterior segment OCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Age Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>WA- NG Telescope Prothesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantable Miniature Telescope for end stage AMD</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telescope prosthesis</intervention_name>
    <description>Monocular implantation of the telescope prosthesis after cataract extraction</description>
    <arm_group_label>WA- NG Telescope Prothesis</arm_group_label>
    <other_name>IMT-NG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WA-NG Telescope Prothesis</intervention_name>
    <description>The WA-NG telescope prosthesis (Figure 1) is the next generation telescopic implantable device which, when combined with the optics of the cornea, constitutes a telephoto system for improvement of visual acuity in patients with severe to profound vision impairment due to bilateral, end-stage age-related macular degeneration. The device is implanted in one of the patient's eyes. In this way, the implanted eye provides central vision and the non-implanted eye can continue to provide peripheral vision.</description>
    <arm_group_label>WA- NG Telescope Prothesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Bi-lateral, stable, moderate to profound (20/80 to 20/800) central vision impairment due
        to bilateral scotoma associated with end-stage macular degeneration, defined as retinal
        finds of bilateral, geographic atrophy or disciform scar with foveal involvment.  Phakic
        in the operative eye.  Must achieve a 5 letter improved with external telescope simulator.

        Exclusion Criteria:

        Evidence of active CNV or any ophthalmic pathology that compromises peripheral vision of
        fellow eye or predisposes eye rubbing.  Previous intraocular of corneal surgery of any
        kind in operative eye.  Retinal disease, optic nerve disease, diabetic retinopathy,
        retinal tears, or any introcular tumor or medical or ophthalmic condition that in the
        opinion of the investigator renders the subject unsuitable for participation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isaac Avni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assaf-Harofeh Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isaac Avni, MD</last_name>
      <phone>+972-8-9779358</phone>
      <email>IzakA@asaf.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Ella Shvalov</last_name>
      <phone>972-8-9204240</phone>
      <email>assaf.research@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Isaac Avni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 30, 2014</lastchanged_date>
  <firstreceived_date>November 14, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Macular Degeneration</keyword>
  <keyword>Visual Impairment</keyword>
  <keyword>Implantable Telescope</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
